Edible medical marijuana articles
-
What marijuana reclassification could mean for medical research
The U.S. pot sector could see an influx of medical research funding from healthcare investors amid renewed interest from pharmaceutical firms, should a proposal to reclassify cannabis as a lower-risk substance be approved, industry experts said. The current classification as a Schedule I substance has limited research into cannabis due to restricted access to cannabis products, regulatory hurdles and funding limitations. Federal research grants are essentially off the table, while...
-
Industry professionals reflect on five years of medical marijuana in Arkansas
Medical marijuana first became available in Arkansas in 2019, and the industry's trajectory has been on a steady incline since.
-
Indiana Democrats cautiously optimistic about medical marijuana legalization next year
INDIANAPOLIS -- As the federal rescheduling of marijuana plays out, and with a new governor soon to be at the helm, some Indiana Democrats have expressed cautious optimism about medical marijuana legalization efforts next session. This comes as the DEA announced it would work to reclassify marijuana as a Schedule III substance last month. For []